Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

IDRA

Idera Pharmaceuticals (IDRA)

Idera Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:IDRA
日付受信時刻ニュースソース見出しコード企業名
2023/06/3005 : 31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/06/2408 : 20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/05/1722 : 50Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/05/1606 : 08Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/05/1305 : 25Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/04/1405 : 32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/04/1105 : 41Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/04/0319 : 00Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/03/3105 : 52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/03/2900 : 29Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/03/2900 : 22Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/02/1507 : 00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/02/0406 : 35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/02/0206 : 44Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/01/3106 : 32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/01/1906 : 55Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/01/1906 : 46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/01/1722 : 00GlobeNewswire Inc.Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic OutlookNASDAQ:IDRAIdera Pharmaceuticals Inc
2023/01/1322 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/01/1122 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/12/2307 : 21Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/12/1006 : 50Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/11/2406 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/11/1807 : 22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/11/1506 : 59Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/11/1506 : 58Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/11/1506 : 05GlobeNewswire Inc.Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
2022/10/0605 : 36Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/10/0406 : 11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/10/0105 : 17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:IDRA

最近閲覧した銘柄

Delayed Upgrade Clock